Below are the most recent publications written about "Hypersensitivity, Delayed" by people in Profiles.
-
Norris MR, Bielory L. Cosmetics and ocular allergy. Curr Opin Allergy Clin Immunol. 2018 10; 18(5):404-410.
-
Phillips EA, Klein GR, Cates HE, Kurtz SM, Steinbeck M. Histological characterization of periprosthetic tissue responses for metal-on-metal hip replacement. J Long Term Eff Med Implants. 2014; 24(1):13-23.
-
Bocian C, Urbanowitz AK, Owens RT, Iozzo RV, G?tte M, Seidler DG. Decorin potentiates interferon-? activity in a model of allergic inflammation. J Biol Chem. 2013 May 03; 288(18):12699-711.
-
Seidler DG, Mohamed NA, Bocian C, Stadtmann A, Hermann S, Sch?fers K, Sch?fers M, Iozzo RV, Zarbock A, G?tte M. The role for decorin in delayed-type hypersensitivity. J Immunol. 2011 Dec 01; 187(11):6108-19.
-
Mahipal A, Terai M, Berd D, Chervoneva I, Patel K, Mastrangelo MJ, Sato T. Tumor-derived interleukin-10 as a prognostic factor in stage III patients undergoing adjuvant treatment with an autologous melanoma cell vaccine. Cancer Immunol Immunother. 2011 Jul; 60(7):1039-45.
-
Lutz E, Yeo CJ, Lillemoe KD, Biedrzycki B, Kobrin B, Herman J, Sugar E, Piantadosi S, Cameron JL, Solt S, Onners B, Tartakovsky I, Choi M, Sharma R, Illei PB, Hruban RH, Abrams RA, Le D, Jaffee E, Laheru D. A lethally irradiated allogeneic granulocyte-macrophage colony stimulating factor-secreting tumor vaccine for pancreatic adenocarcinoma. A Phase II trial of safety, efficacy, and immune activation. Ann Surg. 2011 Feb; 253(2):328-35.
-
Hong J, Bielory L. Allergy to ophthalmic preservatives. Curr Opin Allergy Clin Immunol. 2009 Oct; 9(5):447-53.
-
Rossman MD, Stubbs J, Lee CW, Argyris E, Magira E, Monos D. Human leukocyte antigen Class II amino acid epitopes: susceptibility and progression markers for beryllium hypersensitivity. Am J Respir Crit Care Med. 2002 Mar 15; 165(6):788-94.
-
Jaffee EM, Hruban RH, Biedrzycki B, Laheru D, Schepers K, Sauter PR, Goemann M, Coleman J, Grochow L, Donehower RC, Lillemoe KD, O'Reilly S, Abrams RA, Pardoll DM, Cameron JL, Yeo CJ. Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: a phase I trial of safety and immune activation. J Clin Oncol. 2001 Jan 01; 19(1):145-56.
-
Sobol RE, Shawler DL, Carson C, Van Beveren C, Mercola D, Fakhrai H, Garrett MA, Barone R, Goldfarb P, Bartholomew RM, Brostoff S, Carlo DJ, Royston I, Gold DP. Interleukin 2 gene therapy of colorectal carcinoma with autologous irradiated tumor cells and genetically engineered fibroblasts: a Phase I study. Clin Cancer Res. 1999 Sep; 5(9):2359-65.